Caixin
Sep 01, 2022 08:00 AM

Jiangsu Bioperfectus Technologies Co.,Ltd.’s Net Profit Rose 145.7% in First Half of 2022

Jiangsu Bioperfectus Technologies Co.,Ltd. (江苏硕世生物科技股份有限公司) (688399.SH) reported a net profit of 1.2 billion yuan in the first half of 2022, up 145.7% year-on-year.

Meanwhile, the company posted 3.3 billion yuan in revenue, up 188.9% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 28.9%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST